Literature DB >> 31519455

Sensitivity, specificity, and accuracy of fetal echocardiography for high-risk pregnancies in a tertiary center in Egypt.

S Rakha1, H El Marsafawy2.   

Abstract

BACKGROUND: Advances in fetal echocardiography training among pediatric cardiologists have led to substantial improvements in prenatal detection of congenital heart diseases (CHDs). Nevertheless, diagnostic accuracy varies among centers. Moreover, this subspecialty continues to evolve in developing countries, with limited studies assessing fetal echocardiography sensitivity, specificity, and accuracy in developing countries such as Egypt. SUBJECT AND METHODS: High-risk pregnancies referred for fetal echocardiography from January 2011 to January 2019 were analyzed retrospectively. All of the cases included had one of the high-risk indications for fetal echocardiography. Maternal age and gestational age at the prenatal diagnosis were determined, and detailed fetal and neonatal echocardiograms were documented. The results of fetal and postnatal echocardiography were compared to assess the sensitivity, specificity, and accuracy of fetal echocardiography. A minor lesion was defined when no postnatal intervention was needed and a major anomaly when postnatal cardiac therapy, surgery, or intervention was required.
RESULTS: Out of 615 pregnant patients referred, comparisons between fetal and neonatal echocardiography were possible in 458 fetuses, with 157 patients excluded from the study. The mean maternal age in the study was 26.97±5.871 years and the mean gestational age at referral was 27.24±5.407 weeks. The most common indication for prenatal echocardiography in this cohort was a family history of CHD (142; 31%) followed by nonimmune hydrops (97; 21.18%) and abnormal obstetrical ultrasound screening (64; 13.97%). We had three false-positive minor diagnoses and four false-negative cases with only one requiring intervention. Prenatal diagnosis in this study was accurate in 98.47% of cases. The sensitivity, specificity, and accuracy of fetal echocardiography in the current work were 97.03%, 99.07%, and 98.47, respectively.
CONCLUSION: Fetal echocardiography is considered a highly sensitive specific tool for prenatal detection of congenital heart diseases in high-risk pregnancies even in developing countries. However, minor fetal cardiac disorders are challenging to diagnose and family counseling should emphasize the difficulty of excluding or confirming such lesions.
Copyright © 2019 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fetal echocrdiogrphy; Sensitivity; Specificity

Mesh:

Year:  2019        PMID: 31519455     DOI: 10.1016/j.arcped.2019.08.001

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  4 in total

1.  Prevalence of Gestational Diabetes Mellitus in the Middle East and North Africa, 2000-2019: A Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Rami H Al-Rifai; Noor Motea Abdo; Marília Silva Paulo; Sumanta Saha; Luai A Ahmed
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-26       Impact factor: 5.555

2.  The Mathematical Limitations of Fetal Echocardiography as a Screening Tool in the Setting of a Normal Second-Trimester Ultrasound.

Authors:  Samuel Bellavance; Mikhail-Paul Cardinal; Laurence Gobeil; Marie-Eve Roy-Lacroix; Frédéric Dallaire
Journal:  CJC Open       Date:  2021-06-18

3.  Abnormal findings in fetal echocardiography and maternal disease: A cross-sectional study.

Authors:  Mohammad Reza Alipour; Hossein Moradi; Seyedeh Mahdieh Namayandeh; Fatemeh Majidpoure; Zohreh Pezeshkpour; Mohammadtaghi Sarebanhasanabadi
Journal:  Int J Reprod Biomed       Date:  2022-06-08

4.  Early Assessment of Cardiac Function by Echocardiography in Patients with Gestational Diabetes Mellitus.

Authors:  Pin Wang; Yanyan Peng; LiNa Liu; RuiShuang Jiao; YanHong Zhang; Wei Zhao; YingFeng Liu; CongXin Sun
Journal:  Comput Math Methods Med       Date:  2022-08-27       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.